Alberto Passi


Responsabile dell'U.O.

Cognome e Nome

Alberto Passi

Qualifica

PO

Dipartimento

Department of Medicine and Surgery (DMC)

Settore scientifico disciplinare

BIO/10

E-mail

alberto.passi@uninsubria.it

Telefono

Personale strutturato

Cognome e Nome

Karousou Evgenia

Qualifica

PA

Dipartimento

Department of Medicine and Surgery (DMC)

Ente di appartenenza

University of Insubria Varese

Cognome e Nome

Moretto Paola

Qualifica

Technician

Dipartimento

Department of Medicine and Surgery (DMC)

Ente di appartenenza

University of Insubria Varese

Cognome e Nome

Pallotti Francesco

Qualifica

PA

Dipartimento

Department of Medicine and Surgery (DMC)

Ente di appartenenza

University of Insubria Varese

Cognome e Nome

Vigetti Davide

Qualifica

PA

Dipartimento

Department of Medicine and Surgery (DMC)

Ente di appartenenza

University of Insubria Varese

Cognome e Nome

Viola Manuela

Qualifica

PA

Dipartimento

Department of Medicine and Surgery (DMC)

Ente di appartenenza

University of Insubria Varese

Personale non strutturato

Cognome e Nome

Arianna Parnigoni

Qualifica

Post-doc

Dipartimento

Department of Medicine and Surgery (DMC)

Ente di appartenenza

University of Insubria Varese

Linee di ricerca

The main interest of the Passi’s group is the glycosaminoglycan (GAG) metabolism with particular attention to hyaluronic acid. GAGs are linear sulphated polysaccharides containing uronic acid and hexosamine residues. These molecules are very common in nature and linked to a protein core constitute the proteoglycan family. Hyaluronan (HA) is a special GAG without core protein and completely unsulphated. The aim of our work is the study of the mechanisms driving the GAG synthesis. In order to achieve this target we use a biochemical approach integrated with molecular biology techniques and morphology. To address the GAG chemistry we set up a new electrophoretic method based on the carbohydrate fluorescence (FACE). This method is very simple, fast and able to detect few pmoles of samples. Our preliminary data indicate that over expression in cells of UGDH, the enzyme involved in the synthesis of UDP-glucuronic acid (UDPGlcUA), the UDP uronic precursors of all GAGs, induced an increase in the cells of this precursor and consequently an increase of HA synthesis. On the other hand the silencing of the same enzyme by siRNA induced in the cells the opposite effect, confirming that the availability of UDPGlcUA controls the HA synthesis. In order to quantify the UDP sugars precursors in the cells, we developed a method using HPLC able to separate and quantify all UDP sugars involved in GAG synthesis. Moreover, the altered UDP sugar concentration in the cells was able to alter the expression of the enzymes involved in the UDP sugars synthesis and even the enzymes involved in GAG synthesis. On this basis we are now elucidating the mechanisms involved in this control of enzymes of the pathway of GAG synthesis. For this purpose we also consider the post transcriptional modification of the enzymes using a proteomic approach based on bi-dimensional electrophoresis and mass spectrometry analysis coupled with a genomic approach base on the microarray chips and real time RT-PCR.

Tecnologie in uso dall'UO

  1. 1.
    HPLC and carbohydrate
  2. 2.
    FACE electrophoresis for carbohydrate
  3. 3.
    Confocal Cell Fluorescence
  4. 4.
    Cell cultures
  5. 5.
    Transient transfection by nucleofection
  6. 6.
    Signal silencing using siRNA
  7. 7.
    Cell membrane impedance (ECIS).
  8. 8.
    Carbohydrate Mass spectrometry
  9. 9.
    Real time RT-PCR

Strumentazione

Denominazione

Real time PCR
Ultracentrifuge
HPLC/FPLC with fluorescence detector
Nucleofector and cell cultures
Inverted Fluorescence microscopy
Multiwavelength Fluorescence plate reader

Struttura ove la strumentazione è allocata

Pad. Bassani
Pad. Bassani
Pad. Bassani
Pad. Bassani
Pad. Bassani
Pad. Bassani

Responsabile

Passi
Moretto
Viola
Vigetti
Karousou
Moretto

Pubblicazioni

  1. 1.
    Passi, A., Vigetti, D. (2019). Hyaluronan as tunable drug delivery system. Advanced Drug Delivery 146, pp. 83-96
  2. 2.
    Karamanos NK, Piperigkou Z, Theocharis AD, Watanabe H, Franchi M, Baud S, Brézillon S, Götte M, Passi A, Vigetti D, Ricard-Blum S, Sanderson RD, Neill T, Iozzo RV (2018) Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics. Chem Rev. 118:9152-9232.
  3. 3.
    Viola M, Karousou E, D'Angelo ML, Moretto P, Caon I, Luca G, Passi A, Vigetti D. (2017) Extracellular Matrix in Atherosclerosis: Hyaluronan and Proteoglycans Insights. Curr Med Chem. 23:2958-2971
  4. 4.
    Vigetti D, Deleonibus S, Moretto P, Bowen T, Fischer JW, Grandoch M, Oberhuber A, Love DC, Hanover JA, Cinquetti R, Karousou E, Viola M, D’Angelo ML, HAscall VC, De Luca G, Passi A (2014) Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation. J Biol Chem. 289:28816-28826 (comment on Matrix Biology highlights)
  5. 5.
    Vigetti D, Karousou E, Viola M, Deleonibus S, De Luca G, Passi A (2014) Hyaluronan: biosynthesis and signaling. Biochim Biophys Acta - General Subjects 1840: 2452-2459

Dottorati di ricerca

Componente UO

Davide Vigetti
Manuela Viola

Dottorato di ricerca

Scienze della Vita e Biotecnologie
Scienze della Vita e Biotecnologie

Coordinatore

Silvia Sacchi
Silvia Sacchi

Sede

Varese
Varese